Synopsis

Source of validity: Scientific
Rating (out of 5): 2

d-alpha tocopherol, the natural form of vitamin E, is sometimes used as a supplement to support eye health, including in age-related macular degeneration (AMD). The rationale stems from vitamin E's role as an antioxidant, theorized to protect retinal cells from oxidative damage, a key factor implicated in the progression of AMD. The most prominent evidence comes from the Age-Related Eye Disease Study (AREDS), which evaluated the effect of high-dose antioxidants (vitamin C, vitamin E, beta-carotene, and zinc) on AMD progression. In this large, randomized, controlled trial, the combination supplement (which included vitamin E at 400 IU/day) showed a statistically significant reduction (about 25%) in the risk of progression to advanced AMD in people with intermediate or advanced disease in one eye.

However, it's important to note that vitamin E was not used alone; it was part of a combination formula. Studies examining vitamin E in isolation have not demonstrated a significant benefit for AMD. The general scientific consensus is that vitamin E alone likely does not prevent or treat AMD, but as part of the AREDS or AREDS2 formulations, it may provide some benefit to those at high risk for progression. Therefore, the evidence for d-alpha tocopherol in AMD is modest and primarily relates to its inclusion in multi-nutrient supplements rather than as a standalone therapy.

In summary, the use of d-alpha tocopherol for AMD is scientifically grounded, but the strength of evidence is moderate (2/5) and linked to combination therapy, not monotherapy.

More about d-alpha tocopherol
More about Macular Degeneration

Other ingredients used for Macular Degeneration

Other health conditions supported by d-alpha tocopherol

Products containing d-alpha tocopherol